HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Neurofeedback and standard pharmacological intervention in ADHD: a randomized controlled trial with six-month follow-up.

Abstract
The present study is a randomized controlled trial that aims to evaluate the efficacy of Neurofeedback compared to standard pharmacological intervention in the treatment of attention deficit/hyperactivity disorder (ADHD). The final sample consisted of 23 children with ADHD (11 boys and 12 girls, 7-14 years old). Participants carried out 40 theta/beta training sessions or received methylphenidate. Behavioral rating scales were completed by fathers, mothers, and teachers at pre-, post-treatment, two-, and six-month naturalistic follow-up. In both groups, similar significant reductions were reported in ADHD functional impairment by parents; and in primary ADHD symptoms by parents and teachers. However, significant academic performance improvements were only detected in the Neurofeedback group. Our findings provide new evidence for the efficacy of Neurofeedback, and contribute to enlarge the range of non-pharmacological ADHD intervention choices. To our knowledge, this is the first randomized controlled trial with a six-month follow-up that compares Neurofeedback and stimulant medication in ADHD.
AuthorsVictoria Meisel, Mateu Servera, Gloria Garcia-Banda, Esther Cardo, Inmaculada Moreno
JournalBiological psychology (Biol Psychol) Vol. 94 Issue 1 Pg. 12-21 (Sep 2013) ISSN: 1873-6246 [Electronic] Netherlands
PMID23665196 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Central Nervous System Stimulants
  • Methylphenidate
Topics
  • Adolescent
  • Analysis of Variance
  • Attention Deficit Disorder with Hyperactivity (therapy)
  • Brain Waves (physiology)
  • Central Nervous System Stimulants (therapeutic use)
  • Child
  • Educational Status
  • Electroencephalography
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Methylphenidate (therapeutic use)
  • Neurofeedback (methods)
  • Psychiatric Status Rating Scales
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: